NCT01051700View on ClinicalTrials.gov

A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

January 12, 2010

Primary Completion Date

May 27, 2010

Study Completion Date

May 27, 2010

Conditions

Macular Degeneration

Interventions

DRUG

GW786034

Investigational product

OTHER

Placebo

Placebo

Trial Locations (3)

55404

GSK Investigational Site, Minneapolis

78744

GSK Investigational Site, Austin

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01051700 - A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans | Biotech Hunter | Biotech Hunter